Active, Not Recruiting
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
NCT05479812
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
- Locations
-
- HonorHealth Scottsdale, Arizona, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States